Edesa Biotech Extends COVID-19 Clinical Study to Poland

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. GOOGL

Go back to Edesa Biotech Extends COVID-19 Clinical Study to Poland
(NASDAQ: EDSA) Delayed: 7.95 +0.31 (4.06%)
Previous Close $7.64    52 Week High $ 
Open $7.35    52 Week Low $ 
Day High $8.19    P/E N/A 
Day Low $7.31    EPS $ 
Volume 126,729